基于MRI的膀胱癌影像组学分析:预测病理分级和组织学变异型
回顾性纳入2017年1月至2022年3月接受膀胱MRI且经组织病理学确诊分级和变异型的227例患者,按MRI系统分为训练集131例和测试集96例,从高b值DWI和ADC图提取影像组学特征。分级预测模型在训练集、交叉验证和测试集的AUC分别为0.784、0.786和0.733;变异型预测模型分别为0.748、0.757和0.789。临床-影像组学模型在全数据集上较单纯影像组学模型显著提高分级预测(AUC 0.846 vs 0.756)和变异型预测(AUC 0.810 vs 0.757,p<0.05)。
要点
- 基于高b值DWI和ADC图的MRI影像组学模型可预测膀胱癌病理分级,测试集AUC为0.733。
- 影像组学模型预测组织学变异型测试集AUC为0.789。
- 临床-影像组学模型在全数据集上较单纯影像组学模型显著提高分级和变异型预测效能(p<0.05)。
核心结论
- 基于MRI的影像组学模型可用于预测膀胱癌的病理分级和组织学变异型,性能相对较好。
研究设计与样本
- 回顾性研究,纳入227例接受膀胱MRI且经组织病理学确诊分级和变异型的患者,按MRI系统分为训练集131例和测试集96例,从高b值DWI图像和ADC图手动分割的感兴趣体积中提取影像组学特征,采用五折交叉验证选择最优模型。
诊断标准与关键数值
- 分级预测影像组学模型AUC:训练集0.784、交叉验证0.786、测试集0.733。
- 变异型预测影像组学模型AUC:训练集0.748、交叉验证0.757、测试集0.789。
- 全数据集分级预测临床-影像组学模型AUC 0.846 vs 影像组学模型0.756,p<0.05。
- 全数据集变异型预测临床-影像组学模型AUC 0.810 vs 影像组学模型0.757,p<0.05。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To develop magnetic resonance imaging (MRI)-based radiomics models for the prediction of the pathological grade and histological variant of bladder cancer.
MATERIALS AND METHODS: A total of 227 patients who underwent bladder MRI and had histopathologically confirmed grades and variants were included retrospectively from January 2017 to March 2022. They were assigned to a training set (n=131) and a testing set (n=96) based on the MRI system. MRI-based radiomics features were extracted from manually segmented volumes of interest from high-b-value DWI images and ADC maps. The radiomics models were trained with all possible pipelines in the training set. One optimal model was selected using the fivefold cross-validation method and verified by the testing set according to the pathological results. Univariate and multivariate analyses were performed to identify the significant clinical and imaging factors for developing clinical-radiomics models.
RESULTS: The radiomics model for grade prediction had area under the curve (AUC) values of 0.784, 0.786, and 0.733 in the training, cross-validation, and testing sets, respectively. The radiomics model for variant prediction had AUC values of 0.748, 0.757, and 0.789 in the training, cross-validation, and testing sets, respectively. The performance of the clinical-radiomics model was significantly improved compared with the radiomics models alone for the total dataset (AUC for grade: 0.846 versus 0.756; AUC for variant: 0.810 versus 0.757, p<0.05).
CONCLUSION: MRI-based radiomics models could be used to predict the pathological grade and histological variants of bladder cancer with relatively good performance.
引用
- Wang W, Wang K, Qiu J, et al. MRI-based radiomics analysis of bladder cancer: prediction of pathological grade and histological variant. Clin Radiol. 2023. PMID: 37633748. doi:10.1016/j.crad.2023.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。